Role of Metastasis-Directed Therapy in Genitourinary Cancers
Author:
Publisher
Springer Science and Business Media LLC
Link
https://link.springer.com/content/pdf/10.1007/s11864-024-01199-z.pdf
Reference50 articles.
1. •• Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol [Internet]. 1995 [cited 2023 Feb 19];13(1):8–10. Available from: https://pubmed.ncbi.nlm.nih.gov/7799047/. This was the first paper to propose the theory of oligometastasis.
2. Lievens Y, Guckenberger M, Gomez D, Hoyer M, Iyengar P, Kindts I, et al. Defining oligometastatic disease from a radiation oncology perspective: an ESTRO-ASTRO consensus document. Radiother Oncol. 2020 [cited 2023 Mar 12];148:157–66. Available from: https://pubmed.ncbi.nlm.nih.gov/32388150/
3. Farolfi A, Calderoni L, Mattana F, Mei R, Telo S, Fanti S, et al. Current and emerging clinical applications of PSMA PET diagnostic imaging for prostate cancer. J Nucl Med [Internet]. 2021 [cited 2023 Feb 28];62(5):596–604. Available from: https://pubmed.ncbi.nlm.nih.gov/33712536/
4. • Guckenberger M, Lievens Y, Bouma AB, Collette L, Dekker A, deSouza NM, et al. Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation. Lancet Oncol [Internet]. 2020 [cited 2023 Feb 19];21(1):e18–28. Available from: https://pubmed.ncbi.nlm.nih.gov/31908301/. This consensus guideline proposes a framework with defined criteria to sub-classify oligometastatic disease.
5. Thomas MC, Chen YH, Fite E, Pangilinan A, Bubelo K, Spektor A, et al. Patient and treatment factors associated with improved local control and survival in oligometastatic bone disease: results from a large single-institution experience using stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys [Internet]. 2022 [cited 2023 Mar 15];114(4):747–61. Available from: https://pubmed.ncbi.nlm.nih.gov/35840113/
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3